Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jia Jenny Liu

Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure 3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure 5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure 6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Supplementary Figure 10 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 11 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 12 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 2 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 3 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 4 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 6 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Supplementary Figure 8 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Table 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Table 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence

Table S1 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Table S3 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Table S5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics

Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence